Flanax Pain Reliever
- Product NDC
- 27854-103
- 11-digit product format
- 278540103
- Labeler code
- 27854
- Product ID
- 27854-103_ec7c8e96-24c5-3652-e053-2995a90a196d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Belmora LLC
- Application
- ANDA079096
- Marketing category
- ANDA
- Marketing start
- 2008-12-16
- Marketing end
- 2023-03-31
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 27854-103-06 | 27854010306 | 1 TABLET in 1 POUCH (27854-103-06) | 1 tablet | 2008-12-16 | 0000-00-00 | No | No | Current |
| 27854-103-07 | 27854010307 | 40 PACKET in 1 BOX (27854-103-07) > 1 TABLET in 1 PACKET | 40 packet | 2019-11-04 | 0000-00-00 | No | No | Current |